Norepinephrine Bitartrate in Dextrose

Product NDC
25021-332
Requested package NDC
25021-332-84
11-digit product format
250210332
Labeler code
25021
Product ID
25021-332_df8fbb03-b800-4b63-b4e0-cbfd3e609923
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Norepinephrine Bitartrate
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
Sagent Pharmaceuticals
Application
ANDA220483
Marketing category
ANDA
Marketing start
2026-11-15
Substance
NOREPINEPHRINE BITARTRATE
Active strength
64 ug/mL
Pharmacologic classes
Catecholamine [EPC], Catecholamines [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A220483-001NOREPINEPHRINE BITARTRATE IN 5% DEXTROSENOREPINEPHRINE BITARTRATEEQ 16MG BASE/250ML (EQ 64MCG BASE/ML)SOLUTION / INTRAVENOUSAP2026-03-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A220483-001AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A220483-001NOREPINEPHRINE BITARTRATE IN 5% DEXTROSEEQ 16MG BASE/250ML (EQ 64MCG BASE/ML)SOLUTION / INTRAVENOUSAP2026-03-26d4dbc9d85df4…
2026-10-15 13:18:302026-09A220483-001NOREPINEPHRINE BITARTRATE IN 5% DEXTROSEEQ 16MG BASE/250ML (EQ 64MCG BASE/ML)SOLUTION / INTRAVENOUSAP2026-03-26c2088c7a36db…
2026-09-14 22:38:342026-08A220483-001NOREPINEPHRINE BITARTRATE IN 5% DEXTROSEEQ 16MG BASE/250ML (EQ 64MCG BASE/ML)SOLUTION / INTRAVENOUSAP2026-03-2684e616aacf4f…
2026-08-18 06:07:402026-07A220483-001NOREPINEPHRINE BITARTRATE IN 5% DEXTROSEEQ 16MG BASE/250ML (EQ 64MCG BASE/ML)SOLUTION / INTRAVENOUSAP2026-03-26caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A220483-001NOREPINEPHRINE BITARTRATE IN 5% DEXTROSEEQ 16MG BASE/250ML (EQ 64MCG BASE/ML)SOLUTION / INTRAVENOUSAP2026-03-26a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A220483-001AP1d4dbc9d85df4…
2026-10-15 13:18:302026-09A220483-001AP1c2088c7a36db…
2026-09-14 22:38:342026-08A220483-001AP184e616aacf4f…
2026-08-18 06:07:402026-07A220483-001AP1caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A220483-001AP1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Norepinephrine Bitartrate in Dextrose
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
NOREPINEPHRINE BITARTRATE64 ug/mL

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
25021-332-842502103328410 BAG in 1 CARTON (25021-332-84) / 250 mL in 1 BAG10 bag2026-11-15NoNoCurrent